
Cancer. The body changes. The terrain changes. The rules change. Making sense of biological shifts in remission through lived experience and structured reasoning.
| Platform | Pricing | Freemium | Publishes | Twice weekly | |
|---|---|---|---|---|---|
| Issues | 60 | Founded | 8 months ago | Last Issue | 6 days ago |
| Active | |||||

From metformin and GLP-1 medications to ivermectin and mebendazole: targeting glucose, insulin and cancer-cell growth.
In Parts 1 and 2, we explored how glucose and insulin influence cancer, why certain cancers are especially sensitive to...
From breast and pancreatic cancer to glioblastoma and lymphoma, the metabolic relationship with sugar is far from uniform.
Not all cancers respond to glucose in the same way. Some are particularly efficient at absorbing it. Others respond...
Most people associate blood clots with heart attacks, strokes or sitting still for too long. Few realize how closely blood clotting and cancer are connected.
Cancer increases the risk of dangerous blood clots. These can cause serious compl...
Part 1 of a practical two-part guide to glucose metabolism, nutraceuticals and cancer's metabolic vulnerabilities.
In the previous article, we explored why the familiar statement that “sugar doesn’t feed cancer” overlooks important aspects...
Few statements in oncology frustrate me more than hearing a medical professional tell a cancer patient:
“Sugar doesn’t feed cancer.”
Cancer cannot simply be starved by removing sugar from the diet. That is true. The body will continue to...
Subscribers, engagement, traffic and sponsorship for The Cancer Strategist.
| Subscribers | Engagement | 78 | Monthly Web Visits | ||
|---|---|---|---|---|---|
| Accepts Sponsors | Estimated Cost per Ad | ||||
The writers behind this newsletter.
Helping patients decipher integrative cancer strategies. Sharing what worked, what didn’t and what can backfire, from diagnosis to remission. Which labs matter, what biology tells us, what research shows and how it applies to cancer. Double MS.
You can find recent issues that have been published by The Cancer Strategist on Reletter by scrolling up to where it says Latest Issues. Tap on the link for any of the most recent emails or hit More Issues to see older ones.
To see how many people subscribe to The Cancer Strategist, simply upgrade your Reletter account. We provide readership numbers and lots of other stats for this newsletter so you can decide if it's worth reaching out to.
Newsletter advertising can be extremely effective when it's done right. Before you pitch The Cancer Strategist as a potential sponsor or partner, make sure that you've done your research and checked its newsletter stats with Reletter.
Then, personalize one of our winning pitching templates and send it to the right person using the contact info provided.
Newsletter ad rates (or CPM) vary depending on many factors, including industry, number of subscribers, open rate, ad placement and more.
To find out how much an ad will cost, contact The Cancer Strategist using the contact information provided and ask for a copy of their media kit.
Scroll up to where it says Related Newsletters to see other publications like The Cancer Strategist. You can also search our email newsletter directory to discover other newsletters that cover the topics you're interested in.
Reletter provides this newsletter's website URL above, where you will often find their contact information. We also provide links to associated social media accounts and pitching templates so you can reach out fast.